The Differential Effects of Human Immunodeficiency Virus and Hepatitis C Virus on Bone Microarchitecture and Fracture Risk

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Clinical Infectious Diseases

• Publication date

  2018-04-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/cid/cix1011PMID 29145609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver disease

  2016cited by this paper
• Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study

  2016cited by this paper
• A Meta‐Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX

  2016cited by this paper
• Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis

  2014cited by this paper
• Trabecular Bone Score: A Noninvasive Analytical Method Based Upon the DXA Image

  2014cited by this paper
• Impact of switching from zidovudine to tenofovir disoproxil fumarate on bone mineral density and markers of bone metabolism in virologically suppressed HIV-1 infected patients; a substudy of the PREPARE study.

  2013cited by this paper
• Chronic Viral Hepatitis Is Associated With Low Bone Mineral Density in HIV-Infected Patients, ANRS CO 3 Aquitaine Cohort

  2013cited by this paper
• Hepatitis C Co‐infection and Severity of Liver Disease as Risk Factors for Osteoporotic Fractures Among HIV‐Infected Patients

  2013cited by this paper
• Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis

  2012cited by this paper
• Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study

  2012cited by this paper
• Risk of hip fracture associated with hepatitis c virus infection and hepatitis C/human immunodeficiency virus coinfection

  2012cited by this paper
• Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents

  2012cited by this paper
• Fractures after antiretroviral initiation

  2012cited by this paper
• Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006.

  2011cited by this paper
• Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection.

  2011cited by this paper
• Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans

  2011cited by this paper
• Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.

  2011cited by this paper
• Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study.

  2010cited by this paper
• Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study

  2010cited by this paper
• Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men

  2009cited by this paper
• Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial.

  2009cited by this paper
• Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.

  2008cited by this paper
• Cause-Specific Excess Mortality in Siblings of Patients Co-Infected with HIV and Hepatitis C Virus

  2007cited by this paper
• The association of bone mineral density with HIV infection and antiretroviral treatment in women

  2007cited by this paper
• Mortality in siblings of patients coinfected with HIV and hepatitis C virus.

  2007cited by this paper
• Diagnosis of vertebral fractures by vertebral fracture assessment.

  2006cited by this paper
• Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

  2006cited by this paper
• Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection.

  2005cited by this paper
• AGA technical review on osteoporosis in hepatic disorders.

  2003cited by this paper
• A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C

  2003cited by this paper
• Diagnosis of osteoporosis and assessment of fracture risk.

  2002cited by this paper
• Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

  2000cited by this paper

• Impact of HCV cure on systemic inflammation and bone density, quality, and turnover

  2025cites this paper
• C-reactive protein-to-lymphocyte ratio and trabecular bone score: A mediation analysis of BMI in the NHANES 2005 to 2008 cohort

  2025cites this paper
• Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines

  2025cites this paper
• Seropositive for hepatitis B and C viruses is associated with the risk of decreased bone mineral density in adults: An analysis of studies from the NHANES database

  2023cites this paper
• Fracture Risk and Association With TDF Use Among People With HIV in Large Integrated Health Systems

  2023cites this paper
• Impact of Liver Cirrhosis on Bone Metabolism

  2022cites this paper
• Progress in research of non-cirrhotic chronic viral hepatitis with osteoporosis

  2022cites this paper
• Long Bone Mineral Loss, Bone Microstructural Changes and Oxidative Stress After Eimeria Challenge in Broilers

  2022cites this paper
• BODY COMPOSITION CHANGES IN MEN WITH HIV/HCV COINFECTION, HIV MONOINFECTION, AND HCV MONOINFECTION.

  2022cites this paper
• Musculoskeletal Manifestations and Bone Mineral Density in Chronic Hepatitis C Patients

  2021cites this paper
• Association of SARS-COV2 and Lumbar Spine Fractures: Causal or Coincidental?

  2021cites this paper
• Vitamin D and Calcium Supplement Attenuate Bone Loss among HIV-Infected Patients Receiving Tenofovir Disoproxil Fumarate/Emtricitabine/ Efavirenz: An Open-Label, Randomized Controlled Trial

  2020cites this paper
• Effects of HCV Eradication on Bone mineral density in HIV/HCV Coinfected Patients.

  2020cites this paper
• Bone mineral density and trabecular bone score in treatment-naïve patients with non-cirrhotic hepatitis C virus infection

  2020cites this paper
• Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients

  2020cites this paper
• Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis

  2019cites this paper
• Assessment of trabecular bone score, an index of bone microarchitecture, in HIV positive and HIV negative persons within the HIV UPBEAT cohort

  2019cites this paper
• Alcohol Consumption and Bone Mineral Density in People with HIV and Substance Use Disorder: A Prospective Cohort Study

  2018cites this paper
• Improved fracture prediction using different fracture risk assessment tool adjustments in HIV-infected women

  2018cites this paper